表紙:閉経後骨粗鬆症治療の市場規模:薬剤タイプ別、投与経路別、流通チャネル別、世界予測、2023-2032年
市場調査レポート
商品コード
1385343

閉経後骨粗鬆症治療の市場規模:薬剤タイプ別、投与経路別、流通チャネル別、世界予測、2023-2032年

Postmenopausal Osteoporosis Treatment Market Size - By Drug Type (Bisphosphonates, Hormone Replacement Therapy (HRT)), Route of Administration, Distribution Channel, Global Forecast (2023-2032)

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 120 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.96円
閉経後骨粗鬆症治療の市場規模:薬剤タイプ別、投与経路別、流通チャネル別、世界予測、2023-2032年
出版日: 2023年10月26日
発行: Global Market Insights Inc.
ページ情報: 英文 120 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

閉経後骨粗鬆症治療の市場規模は、2023年から2032年にかけて4.6%のCAGRを示すと推定されます。

医療サービスの助成金、薬価の手頃さ、研究開発イニシアチブの支援などの流入により、効果的な骨粗鬆症管理を助長する環境が整いつつあります。さらに、革新的な治療アプローチの統合を促進する一方で、品質基準と患者の安全性を確保するための政府主導の規制やガイドラインが大幅に増加しています。

さらに、先進的なジェネリック製剤の開発や、重要な治療オプションへの患者のアクセスを向上させるための機器エンジニアリングを通じて、市場ポジションを強化する業界プレイヤーの取り組みが活発化しており、業界の見通しを強化すると思われます。例えば、2023年11月、Teva Pharmaceutical Industries Ltd.の米国子会社であるTeva Pharmaceuticals Inc.は、特定の男女患者の骨粗鬆症治療に処方されるテリパラチド含有注射剤Forteo(R)1のジェネリック医薬品の販売承認を取得しました。

閉経後骨粗鬆症治療業界は、薬剤タイプ、投与経路、流通チャネル、地域に区分されます。

薬剤タイプに基づくと、ホルモン補充療法(HRT)セグメントの市場シェアは、2023年から2032年の間にCAGR 4.8%を獲得すると予測されています。HRTは、骨密度の維持、骨折リスクの低減、症状の管理に役立つことから、閉経後骨粗鬆症の効果的な治療法として浮上しています。さらに、閉経後女性の治療にホルモン補充療法が採用されるようになってきていることと、製剤の研究開発への取り組みが進んでいることが、同分野の拡大を後押しすると思われます。

流通チャネルの面では、病院薬局セグメントの閉経後骨粗鬆症治療産業は、2032年まで3.7%の成長率を記録すると推定されます。病院薬局は、処方された治療へのアクセスを確保するために、骨粗鬆症治療の重要な流通拠点として機能しています。病院薬局から医薬品を入手する利便性と、病院における専門的医療プロフェッショナルの高い利用可能性が、このセグメントの成長に貢献すると思われます。

地域別では、アジア太平洋地域の閉経後骨粗鬆症治療市場は、人口の高齢化と骨粗鬆症管理に対する意識の高まりにより、2032年まで5.2%の成長率を示すと予測されています。2023年に発表されたNCBIの推定によると、アジアは2050年までに骨粗鬆症による骨折の半数以上を占めるようになり、中でも閉経後の女性が最も脆弱です。この地域全体で閉経後女性の骨粗鬆症有病率が上昇していることから、先進的な治療法に対する需要が高まると予想されます。さらに、医療費の増加、医療インフラの改善、政府の取り組みが、この地域における閉経後骨粗鬆症治療の採用をさらに後押しします。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 閉経後骨粗鬆症治療市場の洞察

  • 業界情勢
  • 業界への影響要因
    • 促進要因
      • 高齢女性人口における骨粗鬆症の有病率の増加
      • 研究開発と新薬承認の増加
      • 政府の取り組み
    • 業界の潜在的リスク&課題
      • 治療コンプライアンス
      • 薬の副作用
    • 成長可能性分析
    • 薬剤タイプ別
    • 投与経路別
    • 流通チャネル別
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 企業マトリックス分析
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 閉経後骨粗鬆症治療市場推定・予測:薬剤タイプ別、2018年~2032年

  • 主要動向:薬剤タイプ別
  • ビスフォスフォネート
  • ホルモン補充療法(HRT)
  • 副甲状腺ホルモン
  • エストロゲン受容体モジュレーター
  • その他の薬剤タイプ

第6章 閉経後骨粗鬆症治療市場推定・予測:投与経路別、2018年~2032年

  • 主要動向:投与経路別
  • 経口
  • 非経口
      • 静脈内
      • 筋肉内
      • 皮下
  • 経皮
  • 経鼻

第7章 閉経後骨粗鬆症治療市場推定・予測:流通チャネル別、2018年~2032年

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 閉経後骨粗鬆症治療市場推定・予測:地域別、2018年~2032年

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他中東・アフリカ

第9章 企業プロファイル

  • Eli Lilly and Company
  • Merck Sharp & Dohme Corp.(Merck & Co., Inc.)
  • AbbVie company(Allergan Pharmaceuticals International Ltd.)
  • Amgen Inc.
  • Theramex(PAI and Carlyle)
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Mylan Inc.
  • Chugai Pharma China Co., Ltd.(Roche)
図表

Data Tables

  • TABLE 1 Market revenue, by drug type (2022)
  • TABLE 2 Market revenue, by route of administration (2022)
  • TABLE 3 Market revenue, by distribution channel (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global postmenopausal osteoporosis treatment market size, by region, 2018 - 2022 (USD Million)
  • TABLE 6 Global postmenopausal osteoporosis treatment market size, by region, 2023 - 2032 (USD Million)
  • TABLE 7 Global postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 8 Global postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 9 Global postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 10 Global postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 11 Global postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 12 Global postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 13 Industry impact forces
  • TABLE 14 Bisphosphonates market size, 2018 - 2022 (USD Million)
  • TABLE 15 Bisphosphonates market size, 2023 - 2032 (USD Million)
  • TABLE 16 Hormone replacement therapy (HRT) market size, 2018 - 2022 (USD Million)
  • TABLE 17 Hormone replacement therapy (HRT) market size, 2023 - 2032 (USD Million)
  • TABLE 18 Parathyroid hormone market size, 2018 - 2022 (USD Million)
  • TABLE 19 Parathyroid hormone market size, 2023 - 2032 (USD Million)
  • TABLE 20 Estrogen receptor modulators market size, 2018 - 2022 (USD Million)
  • TABLE 21 Estrogen receptor modulators market size, 2023 - 2032 (USD Million)
  • TABLE 22 Other drug type market size, 2018 - 2022 (USD Million)
  • TABLE 23 Other drug type market size, 2023 - 2032 (USD Million)
  • TABLE 24 Oral market size, 2018 - 2022 (USD Million)
  • TABLE 25 Oral market size, 2023 - 2032 (USD Million)
  • TABLE 26 Parenteral market size, 2018 - 2022 (USD Million)
  • TABLE 27 Parenteral market size, 2023 - 2032 (USD Million)
  • TABLE 28 Intravenous market size, 2018 - 2022 (USD Million)
  • TABLE 29 Intravenous market size, 2023 - 2032 (USD Million)
  • TABLE 30 Intramuscular market size, 2018 - 2022 (USD Million)
  • TABLE 31 Intramuscular market size, 2023 - 2032 (USD Million)
  • TABLE 32 Subcutaneous market size, 2018 - 2022 (USD Million)
  • TABLE 33 Subcutaneous market size, 2023 - 2032 (USD Million)
  • TABLE 34 Transdermal market size, 2018 - 2022 (USD Million)
  • TABLE 35 Transdermal market size, 2023 - 2032 (USD Million)
  • TABLE 36 Nasal market size, 2018 - 2022 (USD Million)
  • TABLE 37 Nasal market size, 2023 - 2032 (USD Million)
  • TABLE 38 Hospital pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 39 Hospital pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 40 Retail pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 41 Retail pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 42 Online pharmacies market size, 2018 - 2022 (USD Million)
  • TABLE 43 Online pharmacies market size, 2023 - 2032 (USD Million)
  • TABLE 44 North America postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 45 North America postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 46 North America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 47 North America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 48 North America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 49 North America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 50 North America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 51 North America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 52 North America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 53 North America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 54 U.S. postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 55 U.S. postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 56 U.S. postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 57 U.S. postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 58 U.S. postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 59 U.S. postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 60 U.S. postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 61 U.S. postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 62 Canada postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 63 Canada postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 64 Canada postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 65 Canada postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 66 Canada postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 67 Canada postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 68 Canada postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 69 Canada postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 70 Europe postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 71 Europe postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 72 Europe postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 73 Europe postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 74 Europe postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 75 Europe postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 76 Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 77 Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 78 Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 79 Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 80 Germany postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 81 Germany postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 82 Germany postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 83 Germany postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 84 Germany postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 85 Germany postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 86 Germany postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 87 Germany postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 88 UK postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 89 UK postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 90 UK postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 91 UK postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 92 UK postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 93 UK postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 94 UK postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 95 UK postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 96 France postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 97 France postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 98 France postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 99 France postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 100 France postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 101 France postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 102 France postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 103 France postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 104 Spain postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 105 Spain postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 106 Spain postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 107 Spain postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 108 Spain postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 109 Spain postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 110 Spain postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 111 Spain postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 112 Italy postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 113 Italy postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 114 Italy postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 115 Italy postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 116 Italy postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 117 Italy postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 118 Italy postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 119 Italy postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 120 Rest of Europe postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 121 Rest of Europe postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 122 Rest of Europe postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 123 Rest of Europe postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 124 Rest of Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 125 Rest of Europe postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 126 Rest of Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 127 Rest of Europe postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 128 Asia Pacific postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 129 Asia Pacific postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 130 Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 131 Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 132 Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 133 Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 134 Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 135 Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 136 Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 137 Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 138 China postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 139 China postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 140 China postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 141 China postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 142 China postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 143 China postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 144 China postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 145 China postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 146 Japan postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 147 Japan postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 148 Japan postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 149 Japan postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 150 Japan postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 151 Japan postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 152 Japan postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 Japan postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 India postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 155 India postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 156 India postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 157 India postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 158 India postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 159 India postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 160 India postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 161 India postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 162 Australia postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 163 Australia postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 164 Australia postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 165 Australia postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 166 Australia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 167 Australia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 168 Australia postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 169 Australia postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 170 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 171 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 172 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 173 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 174 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 175 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 176 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 177 Rest of Asia Pacific postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 178 Latin America postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 179 Latin America postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 180 Latin America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 181 Latin America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 182 Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 183 Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 184 Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 185 Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 186 Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 187 Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 188 Brazil postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 189 Brazil postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 190 Brazil postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 191 Brazil postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 192 Brazil postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 193 Brazil postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 194 Brazil postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 195 Brazil postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 196 Mexico postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 197 Mexico postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 198 Mexico postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 199 Mexico postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 200 Mexico postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 201 Mexico postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 202 Mexico postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 203 Mexico postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 204 Rest of Latin America postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 205 Rest of Latin America postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 206 Rest of Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 207 Rest of Latin America postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 208 Rest of Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 209 Rest of Latin America postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 210 Rest of Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 211 Rest of Latin America postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 212 Middle East & Africa postmenopausal osteoporosis treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 213 Middle East & Africa postmenopausal osteoporosis treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 214 Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 215 Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 216 Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 217 Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 218 Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 219 Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 220 Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 221 Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 222 South Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 223 South Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 224 South Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 225 South Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 226 South Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 227 South Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 228 South Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 229 South Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 230 Saudi Arabia postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 231 Saudi Arabia postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 232 Saudi Arabia postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 233 Saudi Arabia postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 234 Saudi Arabia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 235 Saudi Arabia postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 236 Saudi Arabia postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 237 Saudi Arabia postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 238 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2018 - 2022 (USD Million)
  • TABLE 239 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by drug type, 2023 - 2032 (USD Million)
  • TABLE 240 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 241 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 242 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2018 - 2022 (USD Million)
  • TABLE 243 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by parenteral route of administration, 2023 - 2032 (USD Million)
  • TABLE 244 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 245 Rest of Middle East & Africa postmenopausal osteoporosis treatment market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Postmenopausal osteoporosis treatment industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug type
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by distribution channel
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Competitive analysis of major market players, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022
目次
Product Code: 7186

Postmenopausal Osteoporosis Treatment Market size is estimated to depict 4.6% CAGR from 2023 to 2032 attributed to the surge in supportive government initiatives and healthcare policies worldwide. The influx of subsidized healthcare services, medication affordability, and supportive R&D initiatives are creating an environment conducive to effective osteoporosis management. Additionally, there has been significant increase in government-driven regulations and guidelines for ensuring quality standards and patient safety while promoting the integration of innovative treatment approaches.

Furthermore, the rising efforts by industry players on strengthening their market position through the development of advanced generic formulations and device engineering to enhance patient access to crucial treatment options will augment the industry outlook. For instance, in November 2023, Teva Pharmaceuticals Inc., a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. received approval to market the generic version of Forteo®1, an injectable containing teriparatide, prescribed to treat osteoporosis in certain male and female patients.

The postmenopausal osteoporosis treatment industry is segmented into drug type, route of administration, distribution channel, and region.

Based on drug type, the market share from the hormone replacement therapy (HRT) segment is anticipated to gain 4.8% CAGR between 2023 and 2032. HRT has emerged as an effective treatment approach for postmenopausal osteoporosis as it helps to maintain bone density, reduce fracture risk, and manage symptoms. Additionally, the increasing adoption of hormone replacement therapies to treat postmenopausal women coupled with the ongoing R&D efforts for formulations will propel the segment expansion.

In terms of distribution channel, the postmenopausal osteoporosis treatment industry from the hospital pharmacies segment is estimated to record 3.7% growth rate through 2032. Hospital pharmacies serve as crucial distribution points for osteoporosis medications for ensuring accessibility to prescribed treatments. The convenience of obtaining medications from hospital pharmacies and the higher availability of expert healthcare professionals at hospitals will contribute to the segment growth.

Regionally, the Asia Pacific postmenopausal osteoporosis treatment market is set to exhibit 5.2% growth rate through 2032 driven by the aging population and increasing awareness of osteoporosis management. According to NCBI estimations published in 2023, Asia will account for more than half of all fractures caused by osteoporosis by 2050, with postmenopausal women being the most vulnerable. This rising prevalence of osteoporosis among postmenopausal women across the region is expected to fuel the demand for advanced therapies. Moreover, the rising healthcare expenditure, improving healthcare infrastructure, and government initiatives will further boost the adoption of postmenopausal osteoporosis treatments in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast Calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Postmenopausal osteoporosis treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug type trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Distribution channel trends

Chapter 3 Postmenopausal Osteoporosis Treatment Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of osteoporosis among elderly woman population
      • 3.2.1.2 Rising R&D and new drug approvals
      • 3.2.1.3 Government initiatives
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Treatment compliance
      • 3.2.2.2 Adverse effects of medications
    • 3.2.3 Growth potential analysis
    • 3.2.4 By drug type
    • 3.2.5 By route of administration
    • 3.2.6 By distribution channel
  • 3.3 COVID-19 impact analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by drug type
  • 5.2 Bisphosphonates
  • 5.3 Hormone replacement therapy (HRT)
  • 5.4 Parathyroid hormone
  • 5.5 Estrogen receptor modulators
  • 5.6 Other drug types

Chapter 6 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Oral
  • 6.3 Parenteral
      • 6.3.1.1 Intravenous
      • 6.3.1.2 Intramuscular
      • 6.3.1.3 Subcutaneous
  • 6.4 Transdermal
  • 6.5 Nasal

Chapter 7 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies

Chapter 8 Postmenopausal Osteoporosis Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Eli Lilly and Company
  • 9.2 Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
  • 9.3 AbbVie company (Allergan Pharmaceuticals International Ltd.)
  • 9.4 Amgen Inc.
  • 9.5 Theramex(PAI and Carlyle)
  • 9.6 Sun Pharmaceutical Industries Ltd.
  • 9.7 Pfizer Inc.
  • 9.8 Novartis AG
  • 9.9 Mylan Inc.
  • 9.10 Chugai Pharma China Co., Ltd. (Roche)